Two extremes, neither helpful
One headline says GLP-1 medications “melt muscle.” Another says there is nothing to worry about. Both miss important context. Studies of these medicines report reductions in fat mass and lean mass, not only muscle loss. At the same time, changes in lean tissue deserve attention rather than being brushed aside.
Your medication decisions belong with your prescriber. This article is not a reason to stop treatment; it is a reason to make nourishment and physical function part of the conversation.
Lean mass is not a synonym for muscle
Body-composition measurements often report “lean mass,” which includes water, organs and other non-fat tissues as well as skeletal muscle. A change in that number cannot be interpreted as exactly the same amount of lost muscle. Measurement methods and hydration also affect the result.
Research findings vary by medicine, population and study design. They do not establish that every person will lose the same proportion of muscle or develop weakness. Strength, mobility, endurance and daily function give additional information that a scan or scale cannot provide alone.
Reduced appetite still requires a nutrition plan
A lower appetite does not switch off your need for food. Nausea, early fullness or a busy day can make it easy to miss meals. If intake becomes too low, it may be difficult to get enough protein, energy, fluid and other nutrients.
Try manageable meals or snacks that include protein — yogurt, tofu, eggs, beans, fish or another food you enjoy. Carbohydrates and fats matter too: protein cannot replace an adequately nourishing overall eating pattern. No single protein target fits everyone, particularly when kidney disease or other medical conditions are involved.
Support function, not just a number
Resistance activity, adapted to your ability and medical needs, can help support strength. That might mean bands, chair-based movements, body-weight exercises or weights. Progress can be carrying groceries more comfortably, getting up from a chair or maintaining activities you value — not changing your appearance.
Older adults, people with frailty and those who already have low strength may need closer follow-up. Persistent vomiting, inability to keep fluids down, dizziness or new weakness should be discussed promptly with your care team. A dietitian can help adapt meals to symptoms while your prescriber reviews treatment.
The takeaway
- GLP-1 treatment does not cause only muscle loss, but lean-mass changes deserve context and monitoring.
- Prioritize adequate nourishment, individualized protein intake and accessible strength activity.
- Track how you feel and function, and work with your care team rather than changing medication on your own.
Find meal ideas in the Protein Guide.